The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Exploring Durvalumab With Radiation Therapy in Patients With Urothelial Carcinoma

Monika Joshi, MD
Published Online:4:28 AM, Fri February 9, 2018

During the 2018 Genitourinary Cancers Symposium, Monika Joshi, MD, assistant professor, Penn State Hershey Medical Center, shared results of a phase Ib study of durvalumab (Imfinzi) and radiation therapy (DUART) followed by adjuvant durvalumab in patients with bladder cancer.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.